Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.02 USD | -0.60% | +5.03% | -0.40% |
05-02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.40% | 1.36B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.58% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- JPMorgan Upgrades Vir Biotechnology to Overweight From Neutral, Adjusts Price Target to $34 From $35